NCT00364871View on ClinicalTrials.gov

Efficacy and Safety Study of Combination Therapy to Treat Uncomplicated Obesity

PHASE2CompletedINTERVENTIONAL
Enrollment

410

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
Obesity
Interventions
DRUG

naltrexone and bupropion SR

naltrexone 16, 32 or 48 mg/day and bupropion SR 400 mg/day

Trial Locations (7)

27710

Duke University Medical Center, Durham

28211

Center for Nutrition and Preventive Medicine, Charlotte

29425

MUSC Weight Management Center, Charleston

30909

CSRA Partners in Health, Inc, Augusta

40536

UK Clinical Research Organization, Lexington

70808

Pennington Biomedical Research Center, Baton Rouge

92130

Scripps Clinic Del mar, San Diego

Sponsors
All Listed Sponsors
lead

Orexigen Therapeutics, Inc

INDUSTRY